This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
Lipid Management and Population Health
Accelerated Access Collaborative Resources
Welcome. This web page is for healthcare professionals interested in accessing further information and resources from the Accelerated Access Collaborative’s programme of work on Lipid Management and Population Health.
On this page you will find recordings and slides from Town Hall events alongside accompanying resources such as Frequently Asked Questions, as they become available.
If you have any queries on the resources on this page, or have any questions on the work undertaken by the Accelerated Access Collaborative on lipid management, please contact: england.lipidsphm@nhs.net.
Disclaimer: These resources are part of a collaborative working agreement for lipid management between Novartis and NHS England and Improvement. Both Novartis and NHS England and Improvement contribute resources in the form of skills, expertise, project management and administrative activity. Funding for the collaborative working programme is provided by Novartis. NHS England and Improvement retained editorial control of the agenda and content for meetings, events, and publications.
The webinar held on 8 March 2022 was delivered as a collaboration between the Health Innovation Network and Accelerated Access Collaborative covering the whole lipid management pathway, and was independent to the other events on this page, delivered outside of the aforementioned collaboration.
Town Hall 1: Lipid Management: Delivering on National CVD priorities using a Population Health Management Approach
The first briefing, held on 24 May, focused on improvements and innovation in lipid management, and introduced how novel therapies implemented via a population health management approach can support the Long Term Plan ambitions and address CVD health inequalities.
Speakers included:
- Dr Shahed Ahmad – National Clinical Director for Cardiovascular Disease Prevention at NHS England Improvement
- Dr Tracey Vell MBE – Medical Director of Health Innovation Manchester, and Executive Lead for Primary Care at GM Health and Social Care Partnership
- Matt Whitty – Director of Innovation Research and Life Sciences at NHS England and Improvement and CEO of the Accelerated Access Collaborative
Watch the webinar recording
Town Hall 2: Introducing Innovation to the Lipid Management Pathway using a Population Health Management Approach
The second briefing, held on 23 September, discussed the implementation of the LDL-C lowering therapy inclisiran into the lipid management pathway in England via a Population Health Management approach.
Implementing effective lipid management for patients is one of the national priorities for the NHS in England in the prevention and management of Cardiovascular Disease (CVD). Introducing innovation to the lipid pathway is one of the core components to enable this. NICE published a Final Appraisal Document (FAD) for inclisiran on Wednesday 1st September, recommending it as an option for use in the secondary prevention of CVD. Its approval for use in the NHS comes as part of a collaboration agreement between Government, NHS England and NHS Improvement, and Novartis to deploy this new therapy into the NHS in England via a Population Health Management approach.
Speakers include:
- Matt Whitty, Director of Innovation Research and Life Sciences at NHS England and NHS Improvement, and CEO of the Accelerated Access Collaborative
- Dr Shahed Ahmad, National Clinical Director for Cardiovascular Disease Prevention at NHS England and NHS Improvement
- Dr Kiren Collison, Deputy Medical Director for Primary Care, NHS England and NHS Improvement.
- Dr Jaimini Cegla, Consultant in Metabolic Medicine, Imperial College Healthcare NHS Trust
- Dr Phil Jennings, Chief Executive, Innovation Agency
- Fiona Bride, Director of Market Access, Novartis Pharmaceuticals UK
- Dr Tracey Vell, Clinical Director, Health Innovation Manchester
Watch the webinar recording
Town Hall 3: Sharing early learning: a population health approach to innovation in lipid management
The third briefing, held on 15 December, discussed early learning from the implementation of the LDL-C lowering therapy inclisiran▼ into the lipid management pathway in England via a Population Health Management approach.
The event shares early insights on how PCNs and Health Innovation Networks have started to discuss and embed local pathway changes to include inclisiran as an option. There are also insights from the VICTORION-SPIRIT study.
Watch the webinar recording
The speakers include:
- Jenny Turton, Deputy Director Innovation, Research & Life Sciences, Accelerated Access Collaborative
- Prof. Julia Newton, Clinical Director, North East & North Cumbria AHSN
- Paul Wilson, Senior Lecturer, Centre for Primary Care and Health Services Research, University of Manchester, and Implementation Science research theme lead, NIHR Applied Research Collaboration Greater Manchester
- Dr Matt Fay, GP Principal,The Willows Medical Practice, and Clinical Chief Executive, Affinity Care PCN
- Dr Rani Khatib, Consultant Pharmacist in Cardiology & Cardiovascular Research, Leeds Teaching Hospitals NHS Trust
- Dr Mahmoud Khodadi, Chief Pharmacist & Partner, Affinity Care
- Adele Bunch, Programme Manager, Yorkshire & Humber AHSN
- Julia Reynolds, Associate Director of Transformation, Innovation Agency (AHSN for the North West Coast)
- Nick Clarke, Principal Advisor, Eastern AHSN
- Dr Phil Jennings, Chief Executive, Innovation Agency (AHSN for the North West Coast)
- Sue Critchley, National Lipids Programme Education Lead (AHSN network)
AAC/AHSN Webinar 8 March 2022: Implementing the latest Lipid Management Pathway – a clinical perspective
This webinar was delivered by the Accelerated Access Collaborative (AAC) in collaboration with the Health Innovation Networks to provide information on, and discuss the recently updated AAC lipid management pathway.
The webinar provides an introduction to the revised lipid management pathway and takes a closer look at common clinical scenarios in primary and secondary care when utilising the lipid management pathway.
Watch the recording
The recording includes an audience Q&A, and the speakers include:
- Prof. Julia Newton, Clinical Director, North East & North Cumbria AHSN
- Dr Shahed Ahmad, National Clinical Director for Cardiovascular Disease Prevention, NHSE&I
- Dr Rani Khatib, Consultant Pharmacist in Cardiology & Cardiovascular Research, Leeds Teaching Hospitals NHS Trust
- Dr Matt Fay, GP Principal, The Willows Medical Practice, and Clinical Chief Executive, Affinity Care PCN
- Dr Jaimini Cegla, Consultant in chemical pathology and metabolic medicine, Imperial College Healthcare NHS Trust
- Dr Peter Green, GP Governing Body Member, NHS Kent & Medway CCG
- Mahmoud Khodadi, Chief Pharmacist & Partner – Affinity Care, Clinical Lecturer – Bradford Pharmacy School
- Paul Sullivan, Operational Lead for Diabetes, Affinity Care
Page updated: 9/3/2022
